BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 15792826)

  • 1. Low-dose tacrolimus for two cases of myasthenia gravis with invasive thymoma that relapsed shortly after thymectomy.
    Tsukaguchi M; Shimamura M; Ikeda K; Urai Y; Sasaki I; Deguchi K; Touge T; Takeuchi H; Kuriyama S
    J Neurol Sci; 2005 Apr; 231(1-2):85-8. PubMed ID: 15792826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined treatment with prednisolone and tacrolimus for myasthenia gravis with invasive thymoma.
    Miura S; Azuma K; Yamada K; Takamori S; Kawahara A; Noda K; Ayabe M; Kage M; Aizawa H; Taniwaki T
    Acta Neurol Belg; 2010 Mar; 110(1):107-9. PubMed ID: 20514937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experience with starting tacrolimus postoperatively after transsternal extended thymectomy in patients with myasthenia gravis.
    Ponseti JM; Azem J; Fort JM; López-Cano M; Vilallonga R; Gamez J; Armengol M
    Curr Med Res Opin; 2006 May; 22(5):885-95. PubMed ID: 16709310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow up of thymus in patients with myasthenia gravis.
    Sugawara M; Wada C; Okawa S; Kobayashi M; Abe E; Obara K; Kamada S; Ohnishi H; Toyoshima I
    J Neuroimmunol; 2010 Apr; 221(1-2):121-4. PubMed ID: 20110131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effect of tacrolimus on myasthenia gravis with thymoma.
    Mitsui T; Kunishige M; Ichimiya M; Shichijo K; Endo I; Matsumoto T
    Neurologist; 2007 Mar; 13(2):83-6. PubMed ID: 17351528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tacrolimus in refractory patients with myasthenia gravis: coadministration and tapering of oral prednisolone.
    Shimojima Y; Matsuda M; Gono T; Ishii W; Tokuda T; Ikeda S
    J Clin Neurosci; 2006 Jan; 13(1):39-44. PubMed ID: 16307880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does perioperative high-dose prednisolone have clinical benefits for generalized myasthenia gravis?
    Sekine Y; Kawaguchi N; Hamada C; Sekiguchi H; Yasufuku K; Iyoda A; Shibuya K; Fujisawa T
    Eur J Cardiothorac Surg; 2006 Jun; 29(6):908-13. PubMed ID: 16675232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term therapeutic efficacy and safety of low-dose tacrolimus (FK506) for myasthenia gravis.
    Tada M; Shimohata T; Tada M; Oyake M; Igarashi S; Onodera O; Naruse S; Tanaka K; Tsuji S; Nishizawa M
    J Neurol Sci; 2006 Aug; 247(1):17-20. PubMed ID: 16631797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Eclizumab in the treatment of myasthenia gravis crisis complicating invasive thymoma: a case study of efficacy].
    Yoshizumi K; Kimura T; Ukon S; Watanabe S; Kasama S; Takeda M
    Rinsho Shinkeigaku; 2020 Dec; 60(12):865-868. PubMed ID: 33229836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of myasthenia gravis, who developed minimal change nephrotic syndrome during immunosuppressive therapy after thymectomy].
    Takahashi K; Inoue Y; Matsuda O; Takemura T; Yoshimura A
    Nihon Jinzo Gakkai Shi; 2000 Jul; 42(5):394-8. PubMed ID: 10998921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case report of giant cell myocarditis and myositis observed during the clinical course of invasive thymoma associated with myasthenia gravis.
    Tanahashi N; Sato H; Nogawa S; Satoh T; Kawamura M; Shimoda M
    Keio J Med; 2004 Mar; 53(1):30-42. PubMed ID: 15096726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tacrolimus for myasthenia gravis: a clinical study of 212 patients.
    Ponseti JM; Gamez J; Azem J; López-Cano M; Vilallonga R; Armengol M
    Ann N Y Acad Sci; 2008; 1132():254-63. PubMed ID: 18096852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose intravenous immunoglobulin for the treatment of MuSK antibody-positive seronegative myasthenia gravis.
    Takahashi H; Kawaguchi N; Nemoto Y; Hattori T
    J Neurol Sci; 2006 Sep; 247(2):239-41. PubMed ID: 16876198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postthymectomy myasthenia gravis: relationship with thymoma and antiacetylcholine receptor antibody.
    Nakajima J; Murakawa T; Fukami T; Sano A; Takamoto S; Ohtsu H
    Ann Thorac Surg; 2008 Sep; 86(3):941-5. PubMed ID: 18721587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymomatous myasthenia gravis.
    Pandit L; Rao SN
    J Assoc Physicians India; 1995 Aug; 43(8):543-5. PubMed ID: 8772974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymoma complicated with myasthenia gravis and Good syndrome - a therapeutic conundrum: a case report.
    Paranavitane S; Handagala S; De Silva R; Chang T
    J Med Case Rep; 2019 Nov; 13(1):348. PubMed ID: 31779680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of thymoma and myasthenia gravis: oncological and neurological results of the surgical treatment.
    Lucchi M; Ricciardi R; Melfi F; Duranti L; Basolo F; Palmiero G; Murri L; Mussi A
    Eur J Cardiothorac Surg; 2009 May; 35(5):812-6; discussion 816. PubMed ID: 19237289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of thymoma-associated myasthenia gravis with antibodies against interferon-alpha--a clinico-immunological follow up of the symptoms and its titer].
    Nakamori M; Matsumura T; Saito T; Kunitomi A; Iyama A; Nozaki S; Fujimura H; Shinno S
    Rinsho Shinkeigaku; 2003 Sep; 43(9):544-7. PubMed ID: 14727560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical analysis of myasthenia gravis accompanied by invasive thymoma].
    Wakata N; Kawamura Y; Shin K; Kobayashi T; Kinoshita M
    Rinsho Shinkeigaku; 1991 Mar; 31(3):260-5. PubMed ID: 1893663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of postoperative myasthenic crisis in patients with myasthenia gravis after thymectomy.
    Chu XY; Xue ZQ; Wang RW; Tan QY
    Chin Med J (Engl); 2011 Apr; 124(8):1246-50. PubMed ID: 21543005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.